Leuthold Group LLC Decreases Stake in Encompass Health Corporation $EHC

Leuthold Group LLC lessened its stake in shares of Encompass Health Corporation (NYSE:EHC) by 1.5% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 30,016 shares of the company’s stock after selling 450 shares during the period. Leuthold Group LLC’s holdings in Encompass Health were worth $3,681,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Norges Bank purchased a new stake in shares of Encompass Health during the second quarter valued at $139,536,000. Congress Asset Management Co. purchased a new stake in Encompass Health during the 2nd quarter valued at about $92,691,000. Nuveen LLC purchased a new stake in Encompass Health during the 1st quarter valued at about $50,665,000. T. Rowe Price Investment Management Inc. lifted its holdings in shares of Encompass Health by 25.6% during the first quarter. T. Rowe Price Investment Management Inc. now owns 2,080,918 shares of the company’s stock worth $210,756,000 after purchasing an additional 424,691 shares during the period. Finally, Strs Ohio purchased a new position in Encompass Health during the 1st quarter worth approximately $34,364,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. Truist Financial boosted their target price on shares of Encompass Health from $135.00 to $140.00 and gave the company a “buy” rating in a research report on Thursday, August 14th. KeyCorp boosted their price objective on Encompass Health from $135.00 to $140.00 and gave the company an “overweight” rating in a report on Tuesday, September 16th. Zacks Research lowered Encompass Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 19th. Bank of America boosted their price target on Encompass Health from $145.00 to $160.00 and gave the company a “buy” rating in a report on Wednesday, September 10th. Finally, Weiss Ratings restated a “buy (b+)” rating on shares of Encompass Health in a research report on Wednesday, October 8th. Two investment analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $142.86.

Encompass Health Stock Down 0.0%

Encompass Health stock opened at $116.22 on Friday. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06. The stock has a market capitalization of $11.69 billion, a PE ratio of 21.97, a price-to-earnings-growth ratio of 2.20 and a beta of 0.91. The business has a 50 day simple moving average of $120.47 and a 200-day simple moving average of $119.51. Encompass Health Corporation has a 12 month low of $87.85 and a 12 month high of $127.99.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share (EPS) for the quarter. The firm had revenue of $136.30 million for the quarter. Encompass Health had a net margin of 9.33% and a return on equity of 18.19%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. On average, analysts anticipate that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be paid a $0.19 dividend. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $0.76 dividend on an annualized basis and a yield of 0.7%. Encompass Health’s dividend payout ratio (DPR) is currently 14.37%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.